2023
DOI: 10.1016/j.heliyon.2023.e22091
|View full text |Cite
|
Sign up to set email alerts
|

CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)

Ji-Hea Kim,
Ka-Won Kang,
Yong Park
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 59 publications
0
0
0
Order By: Relevance